Clinical Trial Update: The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy [Phase 2]

View source ↗

Summary

An update on a Phase 2 clinical trial investigating whether bacterial overgrowth and delayed intestinal transit contribute to hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy
• Hepatitis C
• Liver Cirrhosis

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Hepatic Encephalopathy, Hepatitis C | Phase 2 | Status: UNKNOWN